# OpenLongevity: an evidence-first computational foundation for aging research

## Abstract

OpenLongevity is an open-source architecture for connecting heterogeneous aging research into reviewable, reproducible evidence records. It separates source observations from computational interpretation and exposes uncertainty rather than collapsing it into a single claim.

## Motivation and scope

Aging research spans molecular mechanisms, model organisms, observational cohorts, interventions, biomarkers, and clinical trials. OpenLongevity provides shared models, provenance fields, evidence classification, graph relationships, and research-gap heuristics. It is research infrastructure, not a clinical product.

## Architecture and evidence

The platform is organized as ingestion, normalization, evidence extraction, classification, graph storage, and query interfaces. The A–G hierarchy records study-design maturity. Retractions remain visible for auditability and are prevented from improving active confidence summaries.

## Biomarkers and multi-omics

Future adapters can represent epigenomic, transcriptomic, proteomic, metabolomic, genomic, and microbiomic measurements using FAIR-oriented metadata. No single biomarker is treated as a definitive measure of biological age.

## Limitations and future work

The current release uses synthetic fixtures and deterministic heuristics. It does not make clinical claims, infer causality, or replace systematic review. Future work includes validated source adapters, entity resolution, richer graph persistence, reproducible notebooks, and independent scientific review.
